| |
Without ICS
|
With ICS
|
P value
|
Total
|
|---|
|
Age (years)
|
53.3 ± 14.3
|
47.6 ± 12.0
|
0.3495
|
49.9 ± 12.9
|
|
Gender (male/female)
|
2/6
|
5/7
|
0.4439
|
7/13
|
|
Intreval of methcholine provocations (years)
|
2.7 ± 1.0
|
3.4 ± 2.8
|
0.5172
|
3.1 ± 2.2
|
| |
2.9 (1.1–4.0)*
|
2.0 (0.5–8.0)*
| |
2.0 (0.5–8.0)*
|
|
Duration of illness (months)
|
41.5 ± 51.9
|
23.6 ± 31.4
|
0.3466
|
30.8 ± 40.5
|
| |
10.0 (2.0–120.0)*
|
12.5 (2.0–108.0)*
| |
12.0 (2.0–120)*
|
|
Cough threshold (μM)
|
11.1 (1.63)**
|
6.2 (1.59)**
|
0.4163
|
7.8 (1.40)**
|
|
PC20-FEV1 (mg/ml)
|
2.13 (1.52)
|
1.80 (1.35)
|
0.7464
|
1.93 (1.27)
|
|
FVC (% predicted)
|
105.4 ± 14.3
|
103.1 ± 19.1
|
0.7765
|
104.0 ± 17.0
|
|
FEV1 (% predicted)
|
97.4 ± 15.2
|
93.2 ± 16.4
|
0.5763
|
94.9 ± 15.7
|
|
FEV1/FVC (%)
|
73.3 ± 6.9
|
78.1 ± 6.5
|
0.1318
|
76.2 ± 6.9
|
- *; median (range), **; geometric mean (geometric standard error of the mean).
